TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MRNA

Moderna Inc

Healthcare · Biotechnology

190.00$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Moderna Inc (MRNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -526 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MRNA
Line item Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
67 -93 -93 -43 -103 -111 -48 -80 -91 -144 -112 -107 -96 -106 -24 893 1,264 2,971 4,063 3,276 3,310 2,763 304 252 1,662 -1,225 -915 -1,600 622 -989 -1,274 -1,566 825 -1,037 -919 -847 951 -630 -526 -1,052
15 4.7 4.7 5.1 5.9 5.2 5.9 6.5 7.4 7.3 7.5 7.3 8.9 7.0 8.0 8.5 7.7 15 69 70 78 79 76 113 80 78 92 249 202 36 41 52 60 39 57 52 67 59 63 241
– 9.3 9.3 10 11 12 14 15 32 18 21 21 20 20 25 23 25 30 35 40 37 44 50 70 62 75 74 77 79 101 112 112 104 115 130 125 113 104 120 462
42 0.3 0.2 11 41 12 13 14 32 19 21 21 21 21 24 23 88 -20 21 23 -192 -102 -165 -6.0 -32 -221 -189 1,599 – – – – – – – – – – – –
– -1.2 -1.2 34 -82 -56 23 -21 11 -36 -1.3 -11 -1.9 -10 60 1,092 1,436 1,750 1,193 -170 -1,465 -889 -1,815 -904 153 -1,144 574 182 249 60 -146 86 1,737 -211 -297 -818 1,580 553 -18 1,297
33 8.7 8.7 29 12 32 34 26 14 7.6 11 6.7 6.7 6.2 19 19 23 35 30 99 120 132 87 89 92 113 234 140 220 196 182 151 522 127 3.0 33 39 62 37 171
-649 144 144 15 113 -484 -12 116 6.4 -12 -247 113 130 -316 13 -1,178 -190 -180 -3,878 -3,327 -1,138 -3,921 -1,152 945 -1,048 2,011 1,944 789 -538 118 1,649 721 -539 730 564 700 -48 -76 329 905
0.6 0.7 0.7 – 1.5 – – – – – – – 50 – – – 7.0 – – – – 31 – 35 – 25 40 59 – – – – – – – – – – – –
0.4 0.3 0.2 0.0 0.4 – – -8.2 1,217 0.1 3.9 16 2.9 578 1,382 27 7.0 28 36 32 -857 -623 -1,298 -1,006 -402 -526 -628 1.0 0.0 0.0 0.0 0.0 0.0 – – – – – -2.0 –
1.4 0.2 0.5 -1.3 1.4 0.4 -1.3 0.2 12 -0.1 3.9 0.2 -3.0 0.2 -0.2 0.0 -6.3 -2.0 -60 -34 -44 -31 -46 -46 -61 -56 -56 -65 – – – 3.0 -14 2.0 -5.0 -3.0 566 0.0 -7.0 556
473 -0.7 -0.7 0.0 1.5 550 110 -9.4 576 0.3 7.8 16 28 578 1,381 30 44 26 -24 -2.0 -873 -642 -1,327 -1,041 -438 -542 -668 -58 -109 14 34 11 -3.0 4.0 9.0 -1.0 560 17 14 590
-109 51 51 -28 11 -45 50 14 491 -156 -351 22 62 156 1,370 -256 1,118 2,817 161 -53 1,299 -1,800 -2,175 156 176 244 361 -869 -25 -857 409 -833 282 -303 -345 -147 1,462 -688 -185 442
– -102 -102 -72 -115 -143 -82 -106 -105 -152 -123 -114 -102 -112 -43 873 1,241 2,936 4,033 3,177 3,190 2,631 217 163 1,570 -1,338 -1,149 -1,740 402 -1,185 -1,456 -1,717 303 -1,164 -922 -880 912 -692 -563 -1,223

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?